Evaluation and management of adult hypoglycemic disorders: An endocrine society clinical practice guideline

Philip E. Cryer, Lloyd Axelrod, Ashley B. Grossman, Simon R. Heller, Victor Manuel Montori, Elizabeth R. Seaquist, F. John Service

Research output: Contribution to journalArticle

492 Citations (Scopus)

Abstract

Objective: The aim is to provide guidelines for the evaluation and management of adults with hypoglycemic disorders, including those with diabetes mellitus. Evidence: Using the recommendations of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system, the quality of evidence is graded very low (⊕○○○), low (⊕⊕○○), moderate (⊕⊕⊕○), or high (⊕ ⊕ ⊕ ⊕). Conclusions: We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad - symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and resolution of those symptoms or signs after the plasma glucose concentration is raised - is documented. In patients with hypoglycemia without diabetes mellitus, we recommend the following strategy. First, pursue clinical clues to potential hypoglycemic etiologies - drugs, critical illnesses, hormone deficiencies, nonislet cell tumors. In the absence of these causes, the differential diagnosis narrows to accidental, surreptitious, or even malicious hypoglycemia or endogenous hyperinsulinism. In patients suspected of having endogenous hyperinsulinism, measure plasma glucose, insulin, C-peptide, proinsulin, β-hydroxy-butyrate, and circulating oral hypoglycemic agents during an episode of hypoglycemia and measure insulin antibodies. Insulin or insulin secretagogue treatment of diabetes mellitus is the most common cause of hypoglycemia. We recommend the practice of hypoglycemia risk factor reduction - addressing the issue of hypoglycemia, applying the principles of intensive glycemic therapy, and considering both the conventional risk factors and those indicative of compromised defenses against falling plasma glucose concentrations - in persons with diabetes.

Original languageEnglish (US)
Pages (from-to)709-728
Number of pages20
JournalJournal of Clinical Endocrinology and Metabolism
Volume94
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Medical problems
Practice Guidelines
Hypoglycemia
Hypoglycemic Agents
Plasmas
Glucose
Insulin
Insulin Antibodies
Diabetes Mellitus
Butyrates
C-Peptide
Hyperinsulinism
Signs and Symptoms
Tumors
Accidental Falls
Hormones
Risk Reduction Behavior
Critical Illness
Differential Diagnosis
Guidelines

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Evaluation and management of adult hypoglycemic disorders : An endocrine society clinical practice guideline. / Cryer, Philip E.; Axelrod, Lloyd; Grossman, Ashley B.; Heller, Simon R.; Montori, Victor Manuel; Seaquist, Elizabeth R.; Service, F. John.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 3, 03.2009, p. 709-728.

Research output: Contribution to journalArticle

Cryer, Philip E. ; Axelrod, Lloyd ; Grossman, Ashley B. ; Heller, Simon R. ; Montori, Victor Manuel ; Seaquist, Elizabeth R. ; Service, F. John. / Evaluation and management of adult hypoglycemic disorders : An endocrine society clinical practice guideline. In: Journal of Clinical Endocrinology and Metabolism. 2009 ; Vol. 94, No. 3. pp. 709-728.
@article{db12b92773fa4e4c8359cfb72e1afee8,
title = "Evaluation and management of adult hypoglycemic disorders: An endocrine society clinical practice guideline",
abstract = "Objective: The aim is to provide guidelines for the evaluation and management of adults with hypoglycemic disorders, including those with diabetes mellitus. Evidence: Using the recommendations of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system, the quality of evidence is graded very low (⊕○○○), low (⊕⊕○○), moderate (⊕⊕⊕○), or high (⊕ ⊕ ⊕ ⊕). Conclusions: We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad - symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and resolution of those symptoms or signs after the plasma glucose concentration is raised - is documented. In patients with hypoglycemia without diabetes mellitus, we recommend the following strategy. First, pursue clinical clues to potential hypoglycemic etiologies - drugs, critical illnesses, hormone deficiencies, nonislet cell tumors. In the absence of these causes, the differential diagnosis narrows to accidental, surreptitious, or even malicious hypoglycemia or endogenous hyperinsulinism. In patients suspected of having endogenous hyperinsulinism, measure plasma glucose, insulin, C-peptide, proinsulin, β-hydroxy-butyrate, and circulating oral hypoglycemic agents during an episode of hypoglycemia and measure insulin antibodies. Insulin or insulin secretagogue treatment of diabetes mellitus is the most common cause of hypoglycemia. We recommend the practice of hypoglycemia risk factor reduction - addressing the issue of hypoglycemia, applying the principles of intensive glycemic therapy, and considering both the conventional risk factors and those indicative of compromised defenses against falling plasma glucose concentrations - in persons with diabetes.",
author = "Cryer, {Philip E.} and Lloyd Axelrod and Grossman, {Ashley B.} and Heller, {Simon R.} and Montori, {Victor Manuel} and Seaquist, {Elizabeth R.} and Service, {F. John}",
year = "2009",
month = "3",
doi = "10.1210/jc.2008-1410",
language = "English (US)",
volume = "94",
pages = "709--728",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Evaluation and management of adult hypoglycemic disorders

T2 - An endocrine society clinical practice guideline

AU - Cryer, Philip E.

AU - Axelrod, Lloyd

AU - Grossman, Ashley B.

AU - Heller, Simon R.

AU - Montori, Victor Manuel

AU - Seaquist, Elizabeth R.

AU - Service, F. John

PY - 2009/3

Y1 - 2009/3

N2 - Objective: The aim is to provide guidelines for the evaluation and management of adults with hypoglycemic disorders, including those with diabetes mellitus. Evidence: Using the recommendations of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system, the quality of evidence is graded very low (⊕○○○), low (⊕⊕○○), moderate (⊕⊕⊕○), or high (⊕ ⊕ ⊕ ⊕). Conclusions: We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad - symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and resolution of those symptoms or signs after the plasma glucose concentration is raised - is documented. In patients with hypoglycemia without diabetes mellitus, we recommend the following strategy. First, pursue clinical clues to potential hypoglycemic etiologies - drugs, critical illnesses, hormone deficiencies, nonislet cell tumors. In the absence of these causes, the differential diagnosis narrows to accidental, surreptitious, or even malicious hypoglycemia or endogenous hyperinsulinism. In patients suspected of having endogenous hyperinsulinism, measure plasma glucose, insulin, C-peptide, proinsulin, β-hydroxy-butyrate, and circulating oral hypoglycemic agents during an episode of hypoglycemia and measure insulin antibodies. Insulin or insulin secretagogue treatment of diabetes mellitus is the most common cause of hypoglycemia. We recommend the practice of hypoglycemia risk factor reduction - addressing the issue of hypoglycemia, applying the principles of intensive glycemic therapy, and considering both the conventional risk factors and those indicative of compromised defenses against falling plasma glucose concentrations - in persons with diabetes.

AB - Objective: The aim is to provide guidelines for the evaluation and management of adults with hypoglycemic disorders, including those with diabetes mellitus. Evidence: Using the recommendations of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system, the quality of evidence is graded very low (⊕○○○), low (⊕⊕○○), moderate (⊕⊕⊕○), or high (⊕ ⊕ ⊕ ⊕). Conclusions: We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad - symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and resolution of those symptoms or signs after the plasma glucose concentration is raised - is documented. In patients with hypoglycemia without diabetes mellitus, we recommend the following strategy. First, pursue clinical clues to potential hypoglycemic etiologies - drugs, critical illnesses, hormone deficiencies, nonislet cell tumors. In the absence of these causes, the differential diagnosis narrows to accidental, surreptitious, or even malicious hypoglycemia or endogenous hyperinsulinism. In patients suspected of having endogenous hyperinsulinism, measure plasma glucose, insulin, C-peptide, proinsulin, β-hydroxy-butyrate, and circulating oral hypoglycemic agents during an episode of hypoglycemia and measure insulin antibodies. Insulin or insulin secretagogue treatment of diabetes mellitus is the most common cause of hypoglycemia. We recommend the practice of hypoglycemia risk factor reduction - addressing the issue of hypoglycemia, applying the principles of intensive glycemic therapy, and considering both the conventional risk factors and those indicative of compromised defenses against falling plasma glucose concentrations - in persons with diabetes.

UR - http://www.scopus.com/inward/record.url?scp=62349118969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62349118969&partnerID=8YFLogxK

U2 - 10.1210/jc.2008-1410

DO - 10.1210/jc.2008-1410

M3 - Article

C2 - 19088155

AN - SCOPUS:62349118969

VL - 94

SP - 709

EP - 728

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -